Copyright
©The Author(s) 2024.
World J Diabetes. Sep 15, 2024; 15(9): 1916-1931
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1916
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1916
Figure 5 Corilagin reduces oxidative stress in kidney tissue of diabetic nephropathy mice.
A: Representative images of dihydroethidium (DHE) staining for renal superoxide; B: Quantification of DHE intensity in kidney tissue; C-E: Colorimetry was used to measure the levels of MDA, SOD, and CAT in kidney tissue lysate. Data are presented as the mean ± SD (n = 8 in each group). aP < 0.001 vs control group; bP < 0.001 vs DN group. Cor: Corilagin; DN: Diabetic nephropathy.
- Citation: Lou Y, Luan YT, Rong WQ, Gai Y. Corilagin alleviates podocyte injury in diabetic nephropathy by regulating autophagy via the SIRT1-AMPK pathway. World J Diabetes 2024; 15(9): 1916-1931
- URL: https://www.wjgnet.com/1948-9358/full/v15/i9/1916.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i9.1916